Abstract:Drug-induced acute kidney injury (AKI) with a high morbidity and mortality is poorly diagnosed in hospitals and deficiently evaluated in drug discovery. Here, we report the development of molecular renal probes (MRPs) with high renal clearance efficiency for in vivo optical imaging of drug-induced AKI. MRPs specifically activate their near-infrared fluorescence or chemiluminescence signals towards the prodromal biomarkers of AKI including the superoxide anion, <i>N</i>-acetyl-β-<span>d</span>-glucosaminidase and caspase-3, enabling an example of longitudinal imaging of multiple molecular events in the kidneys of living mice. Importantly, they in situ report the sequential occurrence of oxidative stress, lysosomal damage and cellular apoptosis, which precedes clinical manifestation of AKI (decreased glomerular filtration). Such an active imaging mechanism allows MRPs to non-invasively detect the onset of cisplatin-induced AKI at least 36 h earlier than the existing imaging methods. MRPs can also act as exogenous tracers for optical urinalysis that outperforms typical clinical/preclinical assays, demonstrating their clinical promise for early diagnosis of AKI.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the early diagnosis of drug - induced acute kidney injury (Drug - induced Acute Kidney Injury, AKI). AKI is a serious health problem characterized by a rapid decline in kidney function, and it is estimated that 1.7 million people die from it globally every year. Drug - induced AKI accounts for approximately 25% of all AKI cases, mainly due to the nephrotoxicity caused by the use of clinically approved drugs. Currently, drug - induced AKI is under - evaluated during the drug discovery stage, and existing clinical diagnostic methods are unable to identify AKI early because they usually rely on the measurement of serum creatinine (serum creatinine, sCr) and blood urea nitrogen (blood urea nitrogen, BUN), and these indicators are not sensitive to advanced renal dysfunction. To solve this problem, the research team has developed an optical molecular renal probe (Molecular Renal Probes, MRPs) for real - time imaging of early biomarkers of drug - induced AKI in mouse models. These probes can specifically activate their near - infrared fluorescence or chemiluminescence signals, targeting precursor biomarkers of AKI, such as superoxide anion (\(O_2^-\)), N - acetyl - β - D - glucosaminidase (N - acetyl - β - d - glucosaminidase, NAG) and caspase - 3, thereby enabling longitudinal imaging of multiple renal molecular events. Through this active imaging mechanism, MRPs can non - invasively detect cisplatin - induced AKI in mice at least 36 hours in advance, earlier than existing imaging methods. In addition, MRPs can also be used as exogenous tracers for optical urine analysis, and its performance is superior to typical clinical / pre - clinical detection methods, showing its clinical potential in the early diagnosis of AKI.

Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury

Optical Molecular Probes for Imaging and Early Diagnosis of Acute Kidney Injury

An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Construction of a sequence activated fluorescence probe for simultaneous detection of γ-glutamyl transpeptidase and peroxynitrite in acute kidney injury

Visualization of oxidative injury in the mouse kidney using selective superoxide anion fluorescent probes

Discovering a New Drug Against Acute Kidney Injury by Using a Tailored Photoacoustic Imaging Probe

Fluoro‐Photoacoustic Polymeric Renal Reporter for Real‐Time Dual Imaging of Acute Kidney Injury

Precise Monitoring of Drug-Induced Kidney Injury Using an Endoplasmic Reticulum-Targetable Ratiometric Time-Gated Luminescence Probe for Superoxide Anions

Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection

Small-Molecule Photoacoustic Imaging Probe with Aggregation-Enhanced Amplitude for Real-Time Visualization of Acute Kidney Injury

Dual-Modality Detection of Early-Stage Drug-Induced Acute Kidney Injury by an Activatable Probe

Real-Time Monitoring Renal Impairment Due to Drug-Induced AKI and Diabetes-Caused CKD Using an NAG-Activatable NIR-II Nanoprobe

Prediction of Drug-Induced Nephrotoxicity with a Hydroxyl Radical and Caspase Light-Up Dual-Signal Nanoprobe

Non-invasive detection of the early phase of kidney injury by photoacoustic/computed tomography imaging.

Intrarenal pH‐Responsive Self‐Assembly of Luminescent Gold Nanoparticles for Diagnosis of Early Kidney Injury

Screening for Early Biomarkers of Cisplatin-Induced Acute Kidney Injury in Rats Through Serum Metabolomics Technology

Fluorimetric Tool to Discriminate Glomerular and Tubular Injuries In Vivo

Precisely Constructing Renal-Clearable and LAP-Activatable Ratiometric Molecular Probes for Early Diagnosis of Acute and Chronic Kidney Injury Via Optimizing Asymmetric DPP Dyes

Renal-clearable Nanoprobes for Optical Imaging and Early Diagnosis of Diseases